Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 3
1986 2
1987 6
1988 11
1989 19
1990 26
1991 23
1992 29
1993 37
1994 53
1995 55
1996 63
1997 60
1998 75
1999 58
2000 67
2001 79
2002 83
2003 88
2004 91
2005 129
2006 93
2007 90
2008 108
2009 106
2010 145
2011 150
2012 140
2013 162
2014 117
2015 117
2016 131
2017 110
2018 105
2019 121
2020 100
2021 102
2022 101
2023 86
2024 72
2025 89
2026 59

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,043 results

Results by year

Filters applied: . Clear all
Page 1
[Predictors for the Bronchiolitis Obliterans Syndrome in Lung Transplant Patient].
Yang S, Abuduwufuer A, Lv W, Bao F, Hu J. Yang S, et al. Zhongguo Fei Ai Za Zhi. 2020 Jun 20;23(6):496-502. doi: 10.3779/j.issn.1009-3419.2020.101.03. Zhongguo Fei Ai Za Zhi. 2020. PMID: 32517455 Free PMC article. Review. Chinese.
Lung transplantation is the ultimate treatment of end-stage lung disease. After transplantation, the 1-year survival rate is 80%, while the 5-year survival rates remaines at around 50% mainly due to bronchiolitis obliterans syndrome (BOS) …
Lung transplantation is the ultimate treatment of end-stage lung disease. After transplantation, the 1-year surv …
Periostin in Bronchiolitis Obliterans Syndrome after Lung Transplant.
Yeo HJ, Kang J, Kim YH, Cho WH. Yeo HJ, et al. Int J Mol Sci. 2024 Sep 27;25(19):10423. doi: 10.3390/ijms251910423. Int J Mol Sci. 2024. PMID: 39408746 Free PMC article.
The utility of measuring serum periostin levels for predicting the occurrence of bronchiolitis obliterans syndrome (BOS) after lung transplantation remains underexplored. ...Thus, serum periostin levels may serve as biomarkers for predicting a decline …
The utility of measuring serum periostin levels for predicting the occurrence of bronchiolitis obliterans syndrome (BOS) after …
[Bronchiolitis obliterans syndrome in lung transplant recipients].
Antus B, Fillinger J, Csiszér E, Czebe K, Horváth I. Antus B, et al. Orv Hetil. 2005 May 8;146(19):953-8. Orv Hetil. 2005. PMID: 15969307 Review. Hungarian.
Bronchiolitis obliterans syndrome in lung transplant recipients. The leading cause of late graft loss after lung transplantation is bronchiolitis obliterans syndrome. ...Up till now, no effective therapy is available for …
Bronchiolitis obliterans syndrome in lung transplant recipients. The leading cause of late graft loss after l …
Bronchiolitis obliterans.
Sundaresan S. Sundaresan S. Semin Thorac Cardiovasc Surg. 1998 Jul;10(3):221-6. doi: 10.1016/s1043-0679(98)70040-1. Semin Thorac Cardiovasc Surg. 1998. PMID: 9717911 Review.
Hospital survival rates in experienced lung transplantation centers exceed 90%, but late survival for lung allograft recipients is clouded by bronchiolitis obliterans syndrome (BOS). ...BOS seems to affect all lung transplant recip …
Hospital survival rates in experienced lung transplantation centers exceed 90%, but late survival for lung allograft re …
Azithromycin improves lung function in patients with post-lung transplant bronchiolitis obliterans syndrome: a meta-analysis.
Kingah PL, Muma G, Soubani A. Kingah PL, et al. Clin Transplant. 2014 Aug;28(8):906-10. doi: 10.1111/ctr.12401. Epub 2014 Jul 9. Clin Transplant. 2014. PMID: 24931185
INTRODUCTION: Azithromycin has been shown to reverse or halt the decline of forced expiratory volume in one s (FEV1) in patients with bronchiolitis obliterans (BOS) syndrome following lung transplant. The overall effect of azithromycin on the absolute …
INTRODUCTION: Azithromycin has been shown to reverse or halt the decline of forced expiratory volume in one s (FEV1) in patients with bro …
Advances in Understanding Bronchiolitis Obliterans After Lung Transplantation.
Verleden SE, Sacreas A, Vos R, Vanaudenaerde BM, Verleden GM. Verleden SE, et al. Chest. 2016 Jul;150(1):219-25. doi: 10.1016/j.chest.2016.04.014. Epub 2016 May 20. Chest. 2016. PMID: 27212132 Review.
Bronchiolitis obliterans syndrome (BOS) remains a major complication after lung transplantation, causing significant morbidity and mortality in a majority of recipients. ...Pathologic examination reveals obliterative bronchiolitis lesions and a …
Bronchiolitis obliterans syndrome (BOS) remains a major complication after lung transplantation, causing signifi …
Obliterative Bronchiolitis.
Aguilar PR, Michelson AP, Isakow W. Aguilar PR, et al. Transplantation. 2016 Feb;100(2):272-83. doi: 10.1097/TP.0000000000000892. Transplantation. 2016. PMID: 26335918 Review.
Among lung transplant recipients, "bronchiolitis obliterans syndrome," a disorder with clinical and histopathological similarity to OB, represents the leading cause of long-term allograft dysfunction and mortality. ...Unfortunately, OB is poorly unders …
Among lung transplant recipients, "bronchiolitis obliterans syndrome," a disorder with clinical and histopatholo …
Bilateral lung transplantation for Castleman disease with end-stage bronchiolitis obliterans.
Yue B, Huang J, Jing L, Yu H, Wei D, Zhang J, Chen W, Chen J. Yue B, et al. Clin Transplant. 2022 Jan;36(1):e14496. doi: 10.1111/ctr.14496. Epub 2021 Oct 21. Clin Transplant. 2022. PMID: 34590355
Bronchiolitis obliterans (BO) is a severe complication of Castleman disease (CD), a rare lymphoproliferative disease with unclear pathogenesis. ...We retrospectively analyzed the medical records of six consecutive patients with BO and CD who underwent bilateral l …
Bronchiolitis obliterans (BO) is a severe complication of Castleman disease (CD), a rare lymphoproliferative disease with uncl …
Bronchiolitis obliterans in single-lung transplant recipients.
Nathan SD, Ross DJ, Belman MJ, Shain S, Elashoff JD, Kass RM, Koerner SK. Nathan SD, et al. Chest. 1995 Apr;107(4):967-72. doi: 10.1378/chest.107.4.967. Chest. 1995. PMID: 7705163
The presentation and clinical course of bronchiolitis obliterans (BO) in single-lung transplant (SLT) recipients has thus far not been well described. ...The first pattern (n = 6) was characterized by a rapid onset and a relentless progressive course; …
The presentation and clinical course of bronchiolitis obliterans (BO) in single-lung transplant (SLT) recipients …
Association of Fc gamma-binding protein rs1464897604 polymorphism with bronchiolitis obliterans syndrome in lung transplant recipients.
Kang J, Kim YH, Choi E, Seol HY, Yoon SH, Son E, Lee SE, Cho WH, Lee HJ, Oh SH, Yeo HJ. Kang J, et al. J Heart Lung Transplant. 2025 Oct;44(10):1557-1566. doi: 10.1016/j.healun.2025.05.001. Epub 2025 May 27. J Heart Lung Transplant. 2025. PMID: 40441397
BACKGROUND: Bronchiolitis obliterans syndrome (BOS) is a major challenge after lung transplantation (LT) and hematopoietic stem cell transplantation (HSCT), sharing pathological similarities but lacking identified common genetic mutations. METHO …
BACKGROUND: Bronchiolitis obliterans syndrome (BOS) is a major challenge after lung transplantation (LT) and hem …
3,043 results